In 2018, after the FDA approval of additional indications, AbbVie released a citrate-free high-concentration (100mg/ml) formulation of the drug, designed to decrease injection volume for higher ...
When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...
Most are, however, working to get interchangeable status for their biosimilars, and three of them – Organon/Samsung Bioepis’ Hadlima, Sandoz’ Hyrimoz, and Celltrion’s Yuflyma – already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback